1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma
    Journal Article

    Lochrin, S. E.; Cugliari, M. K.; Yeh, R.; Shoushtari, A. N.
    Melanoma Research (2024)

    Fulltext@MSK | Save
  • Three-year overall survival outcomes and correlative analyses in patients with NSCLC and high (50%–89%) versus very high (≥90%) programmed death-ligand 1 expression treated with first-line pembrolizumab or cemiplimab
    Journal Article

    Ricciuti, B.; Elkrief, A.; Lin, J.; Zhang, J.; Alessi, J. V.; Lamberti, G.; Gandhi, M.; Di Federico, A.; Pecci, F.; Wang, X.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Cancer-associated venous thromboembolic disease, version 2.2024
    Guidelines

    Streiff, M. B.; Holmstrom, B.; Angelini, D.; Ashrani, A.; Buckner, T.; Diep, R.; Fertrin, K. Y.; Fogerty, A. E.; Crestani, N. G.; Gangaraju, R.; more...
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Consideration of a novel surgical approach in the management of gastric adenocarcinoma and proximal polyposis syndrome
    Journal Article

    Judge, S. J.; Gearty, S. V.; Catchings, A.; Ranganathan, M.; Roehrl, M. H.; Vardhana, S. A.; Tang, L.; Stadler, Z. K.; Strong, V. E.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Spotlight on polatuzumab vedotin: New standards for diffuse large B-cell lymphoma?
    Review

    Ghione, P.; Salles, G.
    Haematologica (2024)

    Fulltext@MSK | Save
  • Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis
    Research Letter

    Johnson, W. T.; Epstein-Peterson, Z. D.; Ganesan, N.; Pak, T.; Chang, T.; Dao, P.; Moskowitz, A. J.; Stuver, R. N.; Ghione, P.; Galasso, N.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Journal Article

    Danylesko, I.; Shem-Tov, N.; Yerushalmi, R.; Jacoby, E.; Toren, A.; Shouval, R.; Itzhaki, O.; Avigdor, A.; Shimoni, A.; Nagler, A.
    Current Research in Translational Medicine (2024)

    Fulltext@MSK | Save
  • Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma
    Review

    Abramson, J. S.; Stuver, R.; Herrera, A.; Patterson, E.; Wen, Y. P.; Moskowitz, A.
    Critical Reviews in Oncology/Hematology (2024)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease
    Journal Article

    Hayase, E.; Hayase, T.; Mukherjee, A.; Stinson, S. C.; Jamal, M. A.; Ortega, M. R.; Sanchez, C. A.; Ahmed, S. S.; Karmouch, J. L.; Chang, C. C.; more...
    Cell Host & Microbe (2024)

    Fulltext@MSK | Save